Screener / SEC EDGAR /CIK 0001157601 /10-K filed Feb 19, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Madrigal Pharmaceuticals, Inc. MDGL

Compare with peers Embed
Planned sales, announced before they happen

11 trading plans running, 29 Form 144 notices for $96.7M

10-Q, 10-K and Form 144
Plans running now 11 Rebecca Taub, M.D., Mardi Dier, Carole Huntsman, Shannon Kelley, William Sibold, David Soergel, M.D., Richard Levy, M.D., Paul Friedman, M.D.
Plans adopted 22 reported since May 9, 2023 Form 144 notices 29 $96.7M the sellers expected to sell

What MDGL's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Sep 2, 2025 to Mar 1, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Rebecca Taub, M.D.
Director
Adopted 10b5-1 plan Aug 28, 2026 10-Q Nov 3, 2026
Mardi Dier
Chief Financial Officer
Adopted 10b5-1 plan Aug 4, 2026 10-Q Nov 3, 2026
Carole Huntsman
Chief Commercial Officer
Adopted 10b5-1 plan Jul 31, 2026 10-Q Nov 3, 2026
Shannon Kelley
Chief Legal Officer
Adopted 10b5-1 plan Jul 31, 2026 10-Q Nov 3, 2026
William Sibold
Chief Executive Officer and Director
Adopted 10b5-1 plan Jun 5, 2026 10-Q Jul 30, 2026
David Soergel, M.D.
Chief Medical Officer
Adopted 10b5-1 plan Mar 2, 2026 10-Q May 6, 2026
Richard Levy, M.D.
Director
Adopted 10b5-1 plan Feb 20, 2026 10-Q May 6, 2026
Paul Friedman, M.D.
Director
Adopted 10b5-1 plan Sep 10, 2025 10-Q Nov 4, 2025
Rebecca Taub, M.D.
Senior Scientific and Medical Advisor and Director
Adopted 10b5-1 plan Sep 10, 2025 10-Q Nov 4, 2025
Mardi Dier
Chief Financial Officer
Adopted 10b5-1 plan Sep 2, 2025 10-Q Nov 4, 2025
Richard Levy, M.D.
Director
Adopted 10b5-1 plan Aug 14, 2025 10-Q Nov 4, 2025
Richard Levy, MD
Director
Ended plan Jun 16, 2025 10-K Feb 28, 2024
Becky Taub, MD
President of R&D, CMO and Director
Ended plan Apr 3, 2025 10-K Feb 28, 2024
Paul Friedman, MD
Director
Ended plan Apr 3, 2025 10-K Feb 28, 2024
James Daly
Director
Ended plan Jun 27, 2024 10-K Feb 28, 2024
Kenneth Bate
Director
Ended plan Jun 27, 2024 10-K Feb 28, 2024
Fred B. Craves, Ph.D.
Director
Adopted 10b5-1 plan Dec 15, 2023 10-Q Aug 7, 2024
Fred B. Craves, Ph.D.
Director
Adopted 10b5-1 plan Dec 15, 2023 10-Q May 7, 2024
Richard Levy, MD
Director
Adopted 10b5-1 plan Nov 30, 2023 10-Q Oct 31, 2024
What the company wrote
The following table shows the number of shares of our common stock subject to the current Rule 10b5-1 trading arrangements of our Section 16 officers and directors in place as of October 28, 2024: Name of Director or Section 16 Officer Title of Director or Section 16 Officer Date of Adoption, Modification, or Termination Duration of the Plan Aggregate Number of Shares of Common Stock that may be Sold under the Plan Richard Levy, MD Director 11/30/2023 June 16, 2025 15,000
Richard Levy, MD
Director
Adopted 10b5-1 plan Nov 30, 2023 10-Q Aug 7, 2024
Richard Levy, MD
Director
Adopted 10b5-1 plan Nov 30, 2023 10-Q May 7, 2024
Bill Sibold
Chief Executive Officer
Adopted 10b5-1 plan – 10-K Feb 26, 2025
Carole Huntsman
Chief Commercial Officer
Adopted 10b5-1 plan – 10-K Feb 26, 2025
Mardi Dier
Chief Financial Officer
Adopted 10b5-1 plan – 10-K Feb 26, 2025
Paul Friedman, M.D.,
Director
Adopted 10b5-1 plan – 10-Q May 1, 2025
Rebecca Taub, M.D.,
Senior Scientific and Medical Advisor and Director
Adopted 10b5-1 plan – 10-Q May 1, 2025
Shannon Kelley
General Counsel
Adopted 10b5-1 plan – 10-K Feb 26, 2025
Show the other 19 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 6, 2026 SHANNON KELLEY
Officer
1,077 $431K
Sep 28, 2026 PAUL FRIEDMAN
Director
50,000 $25.8M
Sep 11, 2026 WILLIAM SIBOLD
Director, Officer
5,221 $2.8M
Sep 9, 2026 William John Sibold
Officer and Director
6,362 $3.4M
Aug 20, 2026 Shannon Kelley
Officer
664 $337K
Jul 20, 2026 William Sibold
Officer and Director
2,500 $1.4M
Jun 1, 2026 DAVID SOERGEL
Officer
1,042 $518K
May 22, 2026 RICHARD LEVY
Director
5,682 $2.9M
May 18, 2026 David Soergel
Officer
844 $442K
Mar 6, 2026 MARDI DIER
Officer
1,336 $587K
Mar 6, 2026 Mardi Dier
Officer
646 $284K
Mar 6, 2026 William Sibold
Officer and Director
1,663 $731K
Mar 6, 2026 Shannon Kelley
Officer
360 $158K
Mar 6, 2026 Carole Huntsman
Officer
419 $184K
Mar 6, 2026 Rebecca Taub
Director
491 $216K
Mar 2, 2026 Mardi Dier
Officer
1,183 $511K
Jan 26, 2026 CAROLE A HUNTSMAN
Officer
570 $274K
Jan 26, 2026 Carole Huntsman
Officer
340 $163K
Jan 26, 2026 William Sibold
Officer and Director
1,577 $758K
Jan 26, 2026 Rebecca Taub
Director
647 $311K
Jan 20, 2026 SHANNON KELLEY
Officer
429 $215K
Jan 20, 2026 Shannon Kelley
Officer
263 $132K
Jan 20, 2026 Rebecca Taub
Director
2,238 $1.1M
Jan 9, 2026 REBECCA A TAUB
Director
18,650 $10.4M
Dec 10, 2025 PAUL FRIEDMAN
Director
49,600 $27.5M
Dec 10, 2025 REBECCA A TAUB
Director
18,650 $10.3M
Dec 4, 2025 William John Sibold
Officer and Director
2,400 $1.4M
Dec 2, 2025 MARDI C DIER
Officer
4,173 $2.4M
Nov 21, 2025 Carole Huntsman
Officer
1,958 $1.1M
Show the other 21 notices

From the Form 144 XML filed with the SEC, since Nov 21, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDGL/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.